Merck & Daiichi Sankyo Sign $22 Billion Agreement for Antibody Drug Conjugates
Merck Signs Global Development and Commercialization Agreement with Daiichi Sankyo In a major deal, Merck & Co (MSD) of the United States has announced a global development and commercialization agreement with Japan-based Daiichi Sankyo. The agreement is focused on three types of antibody drug conjugates (ADCs) developed by Daiichi Sankyo. With an upfront payment of […]
Exploring the Final Frontier: Pharmaceutical Companies Sending Drugs into Space for Testing
Advancements in Space Exploration Enable Drug Testing in Orbit Global warming has led to an increase in disease outbreaks, prompting countries to urgently develop drugs to combat pathogens. As the world grapples with an aging population, medicine has become indispensable in alleviating and treating various diseases. The National Academies of Sciences, Engineering, and Medicine highlight […]
Bioorchestra Wins First Place in Merck Life Sciences’ Promising Startup Bio Discovery Competition for Their RNA Drug Technology Targeting Brain Cells in Alzheimer’s Disease Treatment
Bioorchestra Wins Merck’s Grand Prize in Promising Startup Bio Discovery Competition In a recent competition hosted by Merck’s Life Science Division, Bioorchestra, a company specializing in the development of treatments for central nervous system (CNS) and rare degenerative diseases, emerged as the winner of the prestigious ‘Merck Grand Prize’. The competition, called the Promising Startup […]
Moderna mRNA cancer vaccine, 79% effective in melanoma patients
[인포스탁데일리=윤서연 기자] moderna A cancer vaccine jointly developed by Moderna and global pharmaceutical company Merck has been shown to be effective in high-risk melanoma patients as a result of interim clinical trials. According to the Wall Street Journal (WSJ) on the 16th (local time), the pharmaceutical companies Moderna and Merck conducted a clinical trial on […]
[0418 섹터분석] Samsung SDI, LG Chem won 1.2 trillion investment Saemangeum plant construction momentum precursor.. Secondary battery theme rising
A secondary battery theme arises due to continued building momentum Cancer vaccine developed by Merck-Moderna, Moderna (MODERNA) makes headlines for proof of efficacy in interim clinical trial Semiconductor-related stocks fell on concerns about a TSMC facility investment cut amid sluggish semiconductor industry conditions [인포스탁데일리=박상철 기자] ◇ Samsung SDI plans to unveil prismatic batteries of the […]
“The corona drug Molnupiravir causes new mutations… it should be stopped” : Dong-A Science
Francis Creek Foundation UK Molnupiravir. Provided by MSD Korea It has been pointed out that Molnupiravir, an oral treatment for new coronavirus infection (COVID-19, Corona 19), should be stopped because it causes a new Corona 19 mutation. Nature reported on the 7th (local time) that a research team led by Theo Sanderson, a researcher at […]
“2023 JP Morgan, large-scale M&A missing… Big Pharma tries to respond to patent expiring”
At the JP Morgan Healthcare Conference 2023, there is no news of large-scale M&A (mergers and acquisitions) compared to previous years, with major global pharma expected to introduce new products and promising pipelines in preparation for coming to patent head. According to Kiwoom Securities’ ‘JP Morgan Healthcare Conference Summary’ report, this JP Morgan Healthcare Conference, […]
“Yamol-nupiravir” aims to arrive in Thailand at the end of March. Which group of covid patients can use it first?
Deputy director of the Bamrasnaradura Institute revealed that the antiviral drug “molnupiravir” will enter Thailand at the end of March. This is the first lot for 50,000 COVID-19 cases, about 2 million pills, indicating that Phase 3 clinical trial results can reduce the mortality rate by more than 89%. Today (3 Mar. 65) “Dr. Weerawat […]
Additional purchase of 400,000 edible medicines… All Pfizer
◀ anchor ▶ The government has decided to purchase an additional 400,000 doses of Pfizer’s edible coronavirus treatment. The treatments that Merck has already decided to introduce are expected to be mainly used for patients who cannot prescribe Pfizer drugs. By Park Yoon-soo. ◀ Report ▶ The amount of edible medicines that the government is […]
Approval of use of ‘Pfizer treatment’… “Purchase plan for 1 million people”
◀ anchor ▶ Pfizer’s edible COVID-19 treatment has been approved for emergency use. ◀ anchor ▶ It will be supplied to home treatment patients from the middle of next month at the earliest. This is reporter Seo Hye-yeon. ◀ Report ▶ Pfizer’s emergency use approval for ‘Paxrovid’, an edible COVID-19 treatment, has been decided. ‘Emergency […]
